Better Therapeutics, Inc. (BTTX) Financials

BTTX Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 10.7 million 20.7 million
June 30, 2023 11.6 million 22.4 million
March 31, 2023 12.8 million 22.6 million
Dec. 31, 2022 22.9 million 23.8 million

BTTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -5.9 million 427000
June 30, 2023 -5.6 million 478000
March 31, 2023 -9.2 million 423
Dec. 31, 2022 -6.7 million 449000

BTTX Net Income

No data available :(

BTTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 6.6 million 7.7 million -
June 30, 2023 6.2 million 8.5 million -
March 31, 2023 6.1 million 9.0 million -
Dec. 31, 2022 15.7 million 10.3 million -

BTTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 38.5 million
June 30, 2023 31.2 million
March 31, 2023 23.8 million
Dec. 31, 2022 23.7 million

BTTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 5000 1.8 million 3.5 million 1.4 million
June 30, 2023 503000 2.2 million 4.8 million 1.7 million
March 31, 2023 521000 3.4 million 5.5 million 2.1 million
Dec. 31, 2022 360000 3.0 million 5.3 million 1.7 million

BTTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 841000
June 30, 2023 - 797000
March 31, 2023 - 755000
Dec. 31, 2022 - 721000

BTTX

Price: $0

52 week price:
0.00
0.00

Earnings Per Share: -1.10 USD

Exchange: OEM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 41300

Market Capitalization: 5452

Links: